Soluble Guanylate Cyclase Stimulators in Heart Failure

被引：12

作者：

Kansakar, Sajog ^{[1
]}

Guragain, Ashish ^{[1
]}

Verma, Deepak ^{[2
]}

Sharma, Prabhat ^{[1
,3
]}

Dhungana, Bibek ^{[4
]}

Bhattarai, Bidit ^{[5
]}

Yadav, Sunil ^{[6
]}

Gautam, Ishant ^{[7
]}

机构：

[1] Manipal Coll Med Sci, Internal Med, Pokhara, Nepal

[2] Calif Inst Behav Neurosci & Psychol, Internal Med Family Med, Fairfield, CA USA

[3] Shankarapur Hosp, Internal Med, Kathmandu, Nepal

[4] KIST Med Coll, Internal Med, Lalitpur, Nepal

[5] Venus Hosp, Internal Med, Kathmandu, Nepal

[6] Topa Primary Hlth Ctr, Internal Med, Rajbiraj, Nepal

[7] Bhaktapur Hosp, Internal Med, Bhaktapur, Nepal

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2021年 / 13卷 / 09期

关键词：

heart failure with reduced ejection fraction (hfref); heart failure with preserved ejection fraction (hfpef); heart failure; guanylate cyclase stimulators; vericiguat; PRESERVED EJECTION FRACTION; NITRIC-OXIDE; VERICIGUAT; PATHOPHYSIOLOGY; CAPACITY; PLACEBO;

D O I：

10.7759/cureus.17781

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Heart failure has a high global burden of morbidity and mortality. Despite significant advances in medical management of heart failure, the prognosis remains poor. This justifies the search for newer therapeutic agents. Recently, soluble guanylate stimulators have demonstrated favorable results in clinical trials. This article aims to summarize the guanylate cyclase signaling pathway, the role of soluble guanylate cyclase stimulators in heart failure, and data from recent clinical trials of these drugs. We concluded that soluble guanylate cyclase stimulators have significant benefits in reducing hospitalizations in patients with heart failure with reduced ejection fraction that are at high risk of cardiovascular events. There appears to be no benefit of these drugs in patients with heart failure with preserved ejection fraction.

引用

页数：7

共 50 条

[41] Design and Rationale of the Soluble Guanylate Cyclase Stimulator in Heart Failure Studies (SOCRATES)
Pieske, Burkert
Butler, Javed
Filippatos, Gerasimos
Lam, Carolyn S. P.
Maggioni, Aldo P.
Ponikowski, Piotr
Shah, Sanjiv J.
Solomon, Scott D.
Kraigher-Krainer, Elisabeth
Samano, Eliana T.
Scalise, Andrea V.
Mueller, Katharina
Roessig, Lothar
Gheorghiade, Mihai
JOURNAL OF CARDIAC FAILURE, 2014, 20 (08) : S39 - S39
[42] Soluble guanylate cyclase (sGC) stimulator vericiguat as a potential treatment for heart failure
Follmann, Markus
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[43] Vericiguat: A Novel Soluble Guanylate Cyclase Stimulator for Use in Patients With Heart Failure
Gupta, Rahul
Lin, Muling
Maitz, Theresa
Egeler, David J. J.
Sood, Aayaan
Aronow, Wilbert S. S.
Rajeswaran, Yasotha
Ahnert, Amy M. M.
Vyas, Apurva V. V.
Frishman, William H. H.
Lanier, Gregg M. M.
CARDIOLOGY IN REVIEW, 2023, 31 (02) : 87 - 92
[44] Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure
Boerrigter, Guido
Costello-Boerrigter, Lisa C.
Cataliotti, Alessandro
Lapp, Harald
Stasch, Johannes-Peter
Burnett, John C., Jr.
HYPERTENSION, 2007, 49 (05) : 1128 - 1133
[45] Design and Rationale of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES)
Pieske, B.
Butler, J.
Filippatos, G.
Lam, C.
Maggioni, A.
Ponikowski, P.
Shah, S.
Solomon, S.
Roessig, L.
Gheorghiade, M.
EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 95 - 95
[46] Cinaciguat, a soluble guanylate cyclase activator for the potential treatment of acute heart failure
Tamargo, Juan
Duarte, Juan
Caballero, Ricardo
Delpon, Eva
CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (09) : 1039 - 1047
[47] Guanylate cyclase stimulators for pulmonary hypertension
Wardle, Andrew J.
Seager, Matthew J.
Wardle, Richard
Tulloh, Robert M. R.
Gibbs, J. Simon R.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (08):
[48] Renal effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence
Stasch, Johannes-Peter
Schlossmann, Jens
Hocher, Berthold
CURRENT OPINION IN PHARMACOLOGY, 2015, 21 : 95 - 104
[49] Soluble guanylate cyclase stimulators for the treatment of hypertension: Discovery of MK-2947
Brockunier, Linda
Stelmach, John
Guo, Jian
Spencer, Tracy
Rosauer, Keith
Bansal, Alka
Cai, Sheng-Jian
Chen, Nancy
Cummings, John
Huang, Li
Johnson, Timothy
Levesque, Sonia
Luo, Lin
Maloney, Kevin
Metzger, Joseph
Mortko, Christopher
Ortega, Karen
Pai, Lee-Yuh
Pereira, Antonio
Salituro, Gino
Shang, Jackie
Shepherd, Cherrie
Xu, Shiyao Sherrie
Yang, Qifeng
Cui, Jisong
Roy, Sophie
Parmee, Emma
Raghavan, Subharekha
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (21)
[50] Exploring New Cardiovascular Pathways Are Soluble Guanylate Cyclase Stimulators the Right Direction?
Michalak, Marek
Armstrong, Paul W.
CIRCULATION-HEART FAILURE, 2018, 11 (03)

← 1 2 3 4 5 →